Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 14.13
  • 52 Week Low: 3.20
  • Currency: UK Pounds
  • Shares Issued: 132.35m
  • Volume: 63,583
  • Market Cap: £4.30m
  • RiskGrade: 435

Tuesday broker round-up UPDATE

Date: Tuesday 10 Jun 2014

LONDON (ShareCast) - ASOS: Goldman Sachs reduces target price from 6250p to 5750p, while upgrading to strong buy.

Avon Rubber: Investec lowers target price from 690p to 680p and downgrades from buy to add.

BAE Systems: Investec downgrades from add to hold with a target price of 430p.

BG Group: Exane downgrades to neutral with its target price at 1350p.

Booker Group: Goldman Sachs lowers target price from 214p to 200p downgrading from strong buy to buy.

Cobham: Investec moves target price from 300p to 310p and maintains a reduce rating.

easyJet: Liberum Capital cuts target price from 1700p to 1650p and reiterates a hold recommendation.

Fenner: Jefferies reduces target price from 490p to 410p and maintains a buy recommendation.

First Group: Deutsche Bank shifts target price from 125p to 130p and keeps a hold recommendation.

First Quantum Minerals: JP Morgan increases target price from 1100p to 1470p upgrading to overweight.

Fuller, Smith and Turner: Numis ups target price from 1050p to 1100p keeping an add rating.

Getech: WH Ireland places both its target price (prev.: 92p) and its buy recommendation under review.

GKN: Investec lowers target price from 435p to 420p and stays with its add rating.

Go-Ahead Group: Deutsche Bank increases target price from 2100p to 2270p and retains a hold recommendation.

Gooch & Housego: N+1 Singer moves target price from 695p to 710p upgrading to buy. FinnCap raises target price from 680p to 750p and upgrades from hold to buy. Investec cuts target price from 790p to 740p retaining a buy recommendation.

Just Retirement: Espirito Santo cuts target price from 295p to 237p, while leaving its buy recommendation unchanged.

Meggitt: Investec moves target price from 560p to 550p and retains its buy recommendation.

Oxford Instruments: Investec places both its target price (prev.: 1500p) and its add recommendation under review.

Phoenix IT: Numis cuts target price from 130p to 95p maintaining a hold recommendation. Investec lowers target price from 138p to 120p and reiterates its hold recommendation.

QinetiQ: Investec downgrades from buy to add with a target price of 225p.

Rolls-Royce Group: Investec raises target price from 1160p to 1225p and keeps a buy recommendation.

Safestay: Westhouse Securities initiates with a target price of 78p and a buy recommendation.

Sepura: Investec ups target price from 160p to 200p and maintains a buy recommendation.

Shire Pharmaceuticals: Deutsche Bank raises target price from 3920p to 4350p and maintains a buy recommendation.

Sports Direct: Goldman Sachs downgrades from strong buy to buy with a target price of 1100p.

Ted Baker: Oriel Securities downgrades from buy to add with a target price of 2200p.

Ultra Electronics: Investec raises target price from 1930p to 2100p upgrading from hold to buy.

WANdisco: UBS cuts target price from 1535p to 1500p, while leaving its buy recommendation remains unchanged.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 3.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 14.13
52 Week Low 3.20
Volume 63,583
Shares Issued 132.35m
Market Cap £4.30m
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
17.71% below the market average17.71% below the market average17.71% below the market average17.71% below the market average17.71% below the market average
13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average13.73% above the sector average
Price Trend
94.35% below the market average94.35% below the market average94.35% below the market average94.35% below the market average94.35% below the market average
89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average89.09% below the sector average
Income Not Available
Growth Not Available

Valirx Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:21 8,692 @ 3.20p
16:07 11,683 @ 3.20p
14:31 1,000 @ 3.20p
13:02 6 @ 3.20p
12:41 5,256 @ 3.20p

Valirx Key Personnel

CFO Gerald Desler
CEO Suzanne Dilly

Top of Page